Tirzepatide Phase 3 study to evaluate real-world weight management and safety in obese adults
Efficacy and Safety of Tirzepatide for Weight Management
Abstract
A Phase 3 real-world study will evaluate tirzepatide 15 mg weekly for weight management and safety in 440 overweight or obese adults.
TitrateLab articles covering Tirzepatide
Written by TitrateLab, separately from the study summarized above.
